Alzamend Neuro, Inc. (ALZN) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2026 | $2.08M | -54.8% |
| 2025 | $4.60M | +628.8% |
| 2024 | $631.6K | -89.3% |
| 2023 | $5.92M | -59.2% |
| 2022 | $14.52M | +398.4% |
| 2021 | $2.91M | +60.6% |
| 2020 | $1.81M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2026 | $2.08M | -54.8% |
| 2025 | $4.60M | +628.8% |
| 2024 | $631.6K | -89.3% |
| 2023 | $5.92M | -59.2% |
| 2022 | $14.52M | +398.4% |
| 2021 | $2.91M | +60.6% |
| 2020 | $1.81M | — |